Ionis Pharmaceuticals (IONS)
(Real Time Quote from BATS)
$38.31 USD
-0.64 (-1.64%)
Updated Jun 10, 2024 10:38 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -1.04 |
EPS Last Quarter | -0.98 |
Last EPS Surprise | 10.91% |
ABR | 1.84 |
Earnings ESP
|
-4.92% |
---|---|
Current Year | -3.95 |
Next Year | -3.36 |
EPS (TTM) | -2.67 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 141.05M | 151.44M | 590.54M | 737.21M |
# of Estimates | 8 | 8 | 8 | 8 |
High Estimate | 161.90M | 163.10M | 622.60M | 867.71M |
Low Estimate | 125.44M | 120.86M | 542.88M | 640.40M |
Year ago Sales | 188.00M | 144.00M | 788.00M | 590.54M |
Year over Year Growth Est. | -24.97% | 5.17% | -25.06% | 24.84% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.04 | -1.03 | -3.95 | -3.36 |
# of Estimates | 9 | 8 | 9 | 10 |
Most Recent Consensus | -0.81 | -0.87 | -3.52 | -3.33 |
High Estimate | -0.79 | -0.86 | -3.45 | -2.25 |
Low Estimate | -1.20 | -1.29 | -4.47 | -4.19 |
Year ago EPS | -0.60 | -1.03 | -2.56 | -3.95 |
Year over Year Growth Est. | -73.33% | 0.00% | -54.30% | 14.98% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 2 | 2 |
Up Last 60 Days | 5 | 4 | 4 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 2 | 5 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.04 | -1.03 | -3.95 | -3.36 |
7 Days Ago | -1.04 | -1.04 | -3.98 | -3.40 |
30 Days Ago | -1.03 | -1.01 | -3.96 | -3.40 |
60 Days Ago | -1.09 | -1.07 | -4.00 | -3.54 |
90 Days Ago | -1.09 | -1.07 | -3.92 | -3.50 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.09 | -1.08 | -4.08 | -3.13 |
Zacks Consensus Estimate | -1.04 | -1.03 | -3.95 | -3.36 |
Earnings ESP | -4.92% | -4.98% | -3.25% | 6.78% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.98 | -0.06 | -1.03 | -0.60 | NA |
Estimate | -1.10 | -0.78 | -1.01 | -0.94 | NA |
Difference | 0.12 | 0.72 | -0.02 | 0.34 | 0.29 |
Surprise | 10.91% | 92.31% | -1.98% | 36.17% | 34.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more